Sign in
Taking peopleNo phase

Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock

Key facts

Who runs it
Hannover Medical School
Where
Austria, Germany, and Switzerland25 sites in 3 countriesChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
274 people, planned
Started
19 Feb 2025
Expected to end
Apr 2028
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Therapeutic Plasma Exchange (TPE)
Record updated
13 March 2025

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • New onset of septic shock (< 24 hrs), (SEPSIS-3 definition)
  • Norepinephrine (NE) dose ≥ 0.4 μg/kg/min ≥ 30 min OR NE ≥ 0.3 μg/kg/min + vasopressin (any dose)
  • Established vascular access suitable for plasma exchange independent of study inclusion (due to established indication of RRT, expected need for RRT within the next 48 hours or other medical reasons as assessed by treating physician team)

Who cannot take part

  • Urogenital focus of infection
  • Age < 18 or > 80 years
  • Pregnancy
  • Heparin-induced thrombocytopenia
  • Known reaction against fresh frozen plasma (FFP)

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

This trial has no sites in United States.

It has sites in 3 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

Randomized, prospective, multicenter, open-label, controlled, parallel-group interventional trial to test the adjunctive effect of therapeutic plasma exchange in patients with early septic shock.

The 2 groups in the trial

  • Therapeutic Plasma Exchange (TPE)Treatment being tested

    1 x TPE with donor Fresh Frozen Plasma (FFPs) (1.2 x individual plasma volume) within the first 6 hrs after randomization. A second TPE can be performed if the patient remains vasopressor dependent ≥ 0.4 ug/kg/min within 24 hours after the first intervention.

  • Standard of Care (SOC)No study treatment, for comparison

    Non-interventional standard of care

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Randomized, Prospective, Multicenter, Open-label, Controlled, Parallel-group Trial Investigating the Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock - 2
Criteria questions
Built from NCT05726825, who can take part
Publications
Record updated
13 March 2025